{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:43:03Z","timestamp":1794505383938,"version":"4.9.1"},"publisher-location":"Cham","reference-count":156,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319208244","type":"print"},{"value":"9783319208251","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-20825-1_15","type":"book-chapter","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T10:48:01Z","timestamp":1443178081000},"page":"423-447","source":"Crossref","is-referenced-by-count":35,"title":["Endocannabinoids and the Digestive Tract and Bladder in Health and Disease"],"prefix":"10.1007","author":[{"given":"Angelo A.","family":"Izzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio G.","family":"Muccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Schicho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/sj.bjp.0704625","volume":"135","author":"M Adami","year":"2002","unstructured":"Adami M, Frati P, Bertini S et al (2002) Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach. Br J Pharmacol 135:598\u2013606","journal-title":"Br J Pharmacol"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.juro.2014.04.008","volume":"192","author":"N Aizawa","year":"2014","unstructured":"Aizawa N, Hedlund P, Fullhase C et al (2014) Inhibition of peripheral FAAH depresses activities of bladder mechanosensitive nerve fibers of the rat. J Urol 192:956\u2013963","journal-title":"J Urol"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1124\/jpet.110.168237","volume":"335","author":"A Alhamoruni","year":"2010","unstructured":"Alhamoruni A, Lee AC, Wright KL et al (2010) Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability. J Pharmacol Exp Ther 335:92\u2013102","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1111\/j.1476-5381.2011.01589.x","volume":"165","author":"A Alhamoruni","year":"2012","unstructured":"Alhamoruni A, Wright KL, Larvin M et al (2012) Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. Br J Pharmacol 165:2598\u20132610","journal-title":"Br J Pharmacol"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2012.07.009","volume":"18","author":"M Alhouayek","year":"2012","unstructured":"Alhouayek M, Muccioli GG (2012) The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity. Trends Mol Med 18:615\u2013625","journal-title":"Trends Mol Med"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.drudis.2014.06.007","volume":"19","author":"M Alhouayek","year":"2014","unstructured":"Alhouayek M, Muccioli GG (2014) Harnessing the anti-inflammatory potential of palmitoylethanolamide. Drug Discov Today 19:1632\u20131639","journal-title":"Drug Discov Today"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1096\/fj.10-176602","volume":"25","author":"M Alhouayek","year":"2011","unstructured":"Alhouayek M, Lambert DM, Delzenne NM et al (2011) Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J 25:2711\u20132721","journal-title":"FASEB J"},{"issue":"2","key":"15_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1096\/fj.14-255208","volume":"29","author":"M Alhouayek","year":"2015","unstructured":"Alhouayek M, Bottemanne P, Subramanian KV et al (2015) N-acylethanolamine hydrolyzing acid amidase inhibition increases colon PEA levels and counteracts murine colitis. FASEB J 29(2):650\u2013661","journal-title":"FASEB J"},{"key":"15_CR9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-2036.2010.04259.x","volume":"31","author":"K Ameloot","year":"2010","unstructured":"Ameloot K, Janssen P, Scarpellini E et al (2010) Endocannabinoid control of gastric sensorimotor function in man. Aliment Pharmacol Ther 31:1123\u20131131","journal-title":"Aliment Pharmacol Ther"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/sj.ki.5002439","volume":"72","author":"G Apodaca","year":"2007","unstructured":"Apodaca G, Balestreire E, Birder LA (2007) The uroepithelial-associated sensory web. Kidney Int 72:1057\u20131064","journal-title":"Kidney Int"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0306-4522(01)00496-1","volume":"109","author":"A Avelino","year":"2002","unstructured":"Avelino A, Cruz C, Nagy I et al (2002) Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 109:787\u2013798","journal-title":"Neuroscience"},{"issue":"Suppl 1","key":"15_CR12","first-page":"81","volume":"12","author":"G Aviello","year":"2008","unstructured":"Aviello G, Romano B, Izzo AA (2008) Cannabinoids and gastrointestinal motility: animal and human studies. Eur Rev Med Pharmacol Sci 12(Suppl 1):81\u201393","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00109-011-0856-x","volume":"90","author":"G Aviello","year":"2012","unstructured":"Aviello G, Romano B, Borrelli F et al (2012) Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med 90:925\u2013934","journal-title":"J Mol Med"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00192-012-1954-1","volume":"24","author":"E Bakali","year":"2013","unstructured":"Bakali E, Elliott RA, Taylor AH et al (2013) Distribution and function of the endocannabinoid system in the rat and human bladder. Int Urogynecol J Pelvic Floor Dysfunct 24:855\u2013863","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/j.1476-5381.2011.01644.x","volume":"165","author":"M Bashashati","year":"2012","unstructured":"Bashashati M, Storr MA, Nikas SP et al (2012) Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice. Br J Pharmacol 165:1556\u20131571","journal-title":"Br J Pharmacol"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1476-5381.2008.00010.x","volume":"156","author":"H Beaumont","year":"2009","unstructured":"Beaumont H, Jensen J, Carlsson A et al (2009) Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans. Br J Pharmacol 156:153\u2013162","journal-title":"Br J Pharmacol"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1124\/mol.106.033118","volume":"71","author":"M Bifulco","year":"2007","unstructured":"Bifulco M, Grimaldi C, Gazzerro P et al (2007) Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. Mol Pharmacol 71:1445\u20131456","journal-title":"Mol Pharmacol"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.beem.2008.10.003","volume":"23","author":"F Borrelli","year":"2009","unstructured":"Borrelli F, Izzo AA (2009) Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Best Pract Res Clin Endocrinol Metab 23:33\u201349","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00109-009-0512-x","volume":"87","author":"F Borrelli","year":"2009","unstructured":"Borrelli F, Aviello G, Romano B et al (2009) Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. J Mol Med 87:1111\u20131121","journal-title":"J Mol Med"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","volume":"85","author":"F Borrelli","year":"2013","unstructured":"Borrelli F, Fasolino I, Romano B et al (2013) Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol 85:1306\u20131316","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"15_CR21","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1093\/carcin\/bgu205","volume":"35","author":"F Borrelli","year":"2014","unstructured":"Borrelli F, Pagano E, Romano B et al (2014) Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. Carcinogenesis 35(12):2787\u20132797","journal-title":"Carcinogenesis"},{"issue":"1","key":"15_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bph.12907","volume":"172","author":"F Borrelli","year":"2015","unstructured":"Borrelli F, Romano B, Petrosino S et al (2015) Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. Br J Pharmacol 172(1):142\u2013158","journal-title":"Br J Pharmacol"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1523\/JNEUROSCI.5166-08.2009","volume":"29","author":"M Brusberg","year":"2009","unstructured":"Brusberg M, Arvidsson S, Kang D et al (2009) CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distension-induced visceral pain in rodents. J Neurosci 29:1554\u20131564","journal-title":"J Neurosci"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"G775","DOI":"10.1152\/ajpgi.00155.2012","volume":"303","author":"M Camilleri","year":"2012","unstructured":"Camilleri M, Lasch K, Zhou W (2012) Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 303:G775\u2013G785","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/sj.bjp.0704339","volume":"134","author":"R Capasso","year":"2001","unstructured":"Capasso R, Izzo AA, Fezza F et al (2001) Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice. Br J Pharmacol 134:945\u2013950","journal-title":"Br J Pharmacol"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/j.gastro.2005.06.018","volume":"129","author":"R Capasso","year":"2005","unstructured":"Capasso R, Matias I, Lutz B et al (2005) Fatty acid amide hydrolase controls mouse intestinal motility in vivo. Gastroenterology 129:941\u2013951","journal-title":"Gastroenterology"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/bjp.2008.177","volume":"154","author":"R Capasso","year":"2008","unstructured":"Capasso R, Borrelli F, Aviello G et al (2008) Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice. Br J Pharmacol 154:1001\u20131008","journal-title":"Br J Pharmacol"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"1006.e9","DOI":"10.1016\/j.urology.2010.12.006","volume":"77","author":"R Capasso","year":"2011","unstructured":"Capasso R, Aviello G, Borrelli F et al (2011) Inhibitory effect of standardized cannabis sativa extract and its ingredient cannabidiol on rat and human bladder contractility. Urology 77:1006.e9\u20131006.e15","journal-title":"Urology"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1111\/bph.12759","volume":"171","author":"R Capasso","year":"2014","unstructured":"Capasso R, Orlando P, Pagano E et al (2014) Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 channels. Br J Pharmacol 171:4026\u20134037","journal-title":"Br J Pharmacol"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0014-2999(02)02830-3","volume":"459","author":"MA Casu","year":"2003","unstructured":"Casu MA, Porcella A, Ruiu S et al (2003) Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract. Eur J Pharmacol 459:97\u2013105","journal-title":"Eur J Pharmacol"},{"key":"15_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010752","volume":"5","author":"A Chouk\u00e8r","year":"2010","unstructured":"Chouk\u00e8r A, Kaufmann I, Kreth S et al (2010) Motion sickness, stress and the endocannabinoid system. PLoS One 5, e10752","journal-title":"PLoS One"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"7691","DOI":"10.1158\/1078-0432.CCR-08-0799","volume":"14","author":"F Cianchi","year":"2008","unstructured":"Cianchi F, Papucci L, Schiavone N et al (2008) Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells. Clin Cancer Res 14:7691\u20137700","journal-title":"Clin Cancer Res"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/nn.2632","volume":"13","author":"JR Clapper","year":"2010","unstructured":"Clapper JR, Moreno-Sanz G, Russo R et al (2010) Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nat Neurosci 13:1265\u20131270","journal-title":"Nat Neurosci"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1124\/jpet.110.169946","volume":"334","author":"NL Cluny","year":"2010","unstructured":"Cluny NL, Keenan CM, Duncan M et al (2010) Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1\/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice. J Pharmacol Exp Ther 334:973\u2013980","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00213-006-0589-7","volume":"190","author":"SK Cross-Mellor","year":"2007","unstructured":"Cross-Mellor SK, Ossenkopp KP, Piomelli D et al (2007) Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat. Psychopharmacology 190:135\u2013143","journal-title":"Psychopharmacology"},{"key":"15_CR36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1096\/fj.05-4943fje","volume":"20","author":"G D\u2019Argenio","year":"2006","unstructured":"D\u2019Argenio G, Valenti M, Scaglione G et al (2006) Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB J 20:568\u2013570","journal-title":"FASEB J"},{"key":"15_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028159","volume":"6","author":"D De Filippis","year":"2011","unstructured":"De Filippis D, Esposito G, Cirillo C et al (2011) Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS One 6, e28159","journal-title":"PLoS One"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1472-8206.2002.00094.x","volume":"16","author":"L De Petrocellis","year":"2002","unstructured":"De Petrocellis L, Bisogno T, Ligresti A et al (2002) Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems. Fundam Clin Pharmacol 16:297\u2013302","journal-title":"Fundam Clin Pharmacol"},{"key":"15_CR39","first-page":"137","volume":"57","author":"A Dembi\u0144ski","year":"2006","unstructured":"Dembi\u0144ski A, Warzecha Z, Ceranowicz P et al (2006) Cannabinoids in acute gastric damage and pancreatitis. J Physiol Pharmacol 57:137\u2013154","journal-title":"J Physiol Pharmacol"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1189\/jlb.0911485","volume":"91","author":"R Di Paola","year":"2012","unstructured":"Di Paola R, Impellizzeri D, Torre A et al (2012) Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice. J Leukoc Biol 91:911\u2013920","journal-title":"J Leukoc Biol"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"G78","DOI":"10.1152\/ajpgi.90285.2008","volume":"295","author":"M Duncan","year":"2008","unstructured":"Duncan M, Mouihate A, Mackie K et al (2008a) Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. Am J Physiol Gastrointest Liver Physiol 295:G78\u2013G87","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"G1255","DOI":"10.1152\/ajpgi.90500.2008","volume":"295","author":"M Duncan","year":"2008","unstructured":"Duncan M, Thomas AD, Cluny NL et al (2008b) Distribution and function of monoacylglycerol lipase in the gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 295:G1255\u2013G1265","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"8948","DOI":"10.1021\/jm3008568","volume":"55","author":"J El Bakali","year":"2012","unstructured":"El Bakali J, Gilleron P, Body-Malapel M et al (2012) 4-Oxo-1,4-dihydropyridines as selective CB(2) cannabinoid receptor ligands. Part 2: discovery of new agonists endowed with protective effect against experimental colitis. J Med Chem 55:8948\u20138952","journal-title":"J Med Chem"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2982.2006.00834.x","volume":"18","author":"T Esfandyari","year":"2006","unstructured":"Esfandyari T, Camilleri M, Ferber I et al (2006) Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil 18:831\u2013838","journal-title":"Neurogastroenterol Motil"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"G137","DOI":"10.1152\/ajpgi.00565.2006","volume":"293","author":"T Esfandyari","year":"2007","unstructured":"Esfandyari T, Camilleri M, Busciglio I et al (2007) Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol 293:G137\u2013G145","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/gutjnl-2013-305005","volume":"63","author":"G Esposito","year":"2014","unstructured":"Esposito G, Capoccia E, Turco F et al (2014) Palmitoylethanolamide improves colon inflammation through an enteric glia\/toll like receptor 4-dependent PPAR-alpha activation. Gut 63:1300\u20131312","journal-title":"Gut"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000542-200103000-00023","volume":"94","author":"WP Farquhar-Smith","year":"2001","unstructured":"Farquhar-Smith WP, Rice AS (2001) Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder. Anesthesiology 94:507\u2013513","journal-title":"Anesthesiology"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0304-3959(01)00419-5","volume":"97","author":"WP Farquhar-Smith","year":"2002","unstructured":"Farquhar-Smith WP, Jaggar SI, Rice AS (2002) Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain 97:11\u201321","journal-title":"Pain"},{"key":"15_CR49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","volume":"48","author":"CC Felder","year":"1995","unstructured":"Felder CC, Joyce KE, Briley EM et al (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443\u2013450","journal-title":"Mol Pharmacol"},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.pain.2014.05.005","volume":"155","author":"CC Feng","year":"2014","unstructured":"Feng CC, Yan XJ, Chen X et al (2014) Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats. Pain 155:1591\u20131604","journal-title":"Pain"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"e550","DOI":"10.1111\/nmo.12158","volume":"25","author":"J Fichna","year":"2013","unstructured":"Fichna J, Sibaev A, Salaga M et al (2013) The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice. Neurogastroenterol Motil 25:e550\u2013e559","journal-title":"Neurogastroenterol Motil"},{"key":"15_CR52","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/nmo.12272","volume":"26","author":"J Fichna","year":"2014","unstructured":"Fichna J, Salaga M, Stuart J et al (2014) Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides. Neurogastroenterol Motil 26:470\u2013481","journal-title":"Neurogastroenterol Motil"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00192-006-0086-x","volume":"17","author":"RM Freeman","year":"2006","unstructured":"Freeman RM, Adekanmi O, Waterfield MR et al (2006) The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct 17:636\u2013641","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature01921","volume":"425","author":"J Fu","year":"2003","unstructured":"Fu J, Gaetani S, Oveisi F et al (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425:90\u201393","journal-title":"Nature"},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.juro.2008.11.079","volume":"181","author":"C Gratzke","year":"2009","unstructured":"Gratzke C, Streng T, Park A et al (2009) Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. J Urol 181:1939\u20131948","journal-title":"J Urol"},{"key":"15_CR155","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.juro.2010.09.080","volume":"185","author":"C Gratzke","year":"2011","unstructured":"Gratzke C, Streng T, Stief CG et al (2011) Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction. J Urol 185:731\u2013736","journal-title":"J Urol"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/ijc.22917","volume":"121","author":"A Greenhough","year":"2007","unstructured":"Greenhough A, Patsos HA, Williams AC et al (2007) The cannabinoid \u03949-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Int J Cancer 121:2172\u20132180","journal-title":"Int J Cancer"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"G539","DOI":"10.1152\/ajpgi.00064.2009","volume":"297","author":"JR Grider","year":"2009","unstructured":"Grider JR, Mahavadi S, Li Y et al (2009) Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoids. Am J Physiol Gastrointest Liver Physiol 297:G539\u2013G549","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1001\/jama.1995.03520470083037","volume":"273","author":"L Grinspoon","year":"1995","unstructured":"Grinspoon L, Bakalar JB (1995) Marihuana as medicine. A plea for reconsideration. JAMA 273:1875\u20131876","journal-title":"JAMA"},{"key":"15_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023003","volume":"6","author":"SB Gustafsson","year":"2011","unstructured":"Gustafsson SB, Palmqvist R, Henriksson ML et al (2011) High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer. PLoS One 6, e23003","journal-title":"PLoS One"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.mce.2013.10.002","volume":"382","author":"K Gyires","year":"2014","unstructured":"Gyires K, R\u00f3nai AZ, Z\u00e1dori ZS et al (2014) Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats. Mol Cell Endocrinol 382:971\u2013978","journal-title":"Mol Cell Endocrinol"},{"key":"15_CR61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejphar.2006.07.024","volume":"546","author":"VL Haller","year":"2006","unstructured":"Haller VL, Cichewicz DL, Welch SP (2006) Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice. Eur J Pharmacol 546:60\u201368","journal-title":"Eur J Pharmacol"},{"key":"15_CR62","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cyto.2013.10.006","volume":"65","author":"BS Harvey","year":"2014","unstructured":"Harvey BS, Sia TC, Wattchow DA et al (2014) Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. Cytokine 65:236\u2013244","journal-title":"Cytokine"},{"key":"15_CR63","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.urology.2008.03.044","volume":"72","author":"MH Hayn","year":"2008","unstructured":"Hayn MH, Ballesteros I, de Miguel F et al (2008) Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder. Urology 72:1174\u20131178","journal-title":"Urology"},{"key":"15_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.phrs.2009.03.008","volume":"60","author":"AA Izzo","year":"2009","unstructured":"Izzo AA, Camilleri M (2009) Cannabinoids in intestinal inflammation and cancer. Pharmacol Res 60:117\u2013125","journal-title":"Pharmacol Res"},{"key":"15_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pharmthera.2009.12.005","volume":"126","author":"AA Izzo","year":"2010","unstructured":"Izzo AA, Sharkey KA (2010) Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 126:21\u201338","journal-title":"Pharmacol Ther"},{"key":"15_CR66","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/sj.bjp.0703265","volume":"129","author":"AA Izzo","year":"2000","unstructured":"Izzo AA, Pinto L, Borrelli F et al (2000) Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil. Br J Pharmacol 129:1627\u20131632","journal-title":"Br J Pharmacol"},{"key":"15_CR67","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/sj.bjp.0704293","volume":"134","author":"AA Izzo","year":"2001","unstructured":"Izzo AA, Fezza F, Capasso R et al (2001) Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol 134:563\u2013570","journal-title":"Br J Pharmacol"},{"key":"15_CR68","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0016-5085(03)00892-8","volume":"125","author":"AA Izzo","year":"2003","unstructured":"Izzo AA, Capasso F, Costagliola A et al (2003) An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice. Gastroenterology 125:765\u2013774","journal-title":"Gastroenterology"},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00109-007-0248-4","volume":"86","author":"AA Izzo","year":"2008","unstructured":"Izzo AA, Aviello G, Petrosino S et al (2008) Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. J Mol Med 86:89\u201398","journal-title":"J Mol Med"},{"key":"15_CR70","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/j.1476-5381.2012.01879.x","volume":"166","author":"AA Izzo","year":"2012","unstructured":"Izzo AA, Capasso R, Aviello G et al (2012) Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br J Pharmacol 166:1444\u20131460","journal-title":"Br J Pharmacol"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0304-3959(98)00041-4","volume":"76","author":"SI Jaggar","year":"1998","unstructured":"Jaggar SI, Hasnie FS, Sellaturay S et al (1998) The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76:189\u2013199","journal-title":"Pain"},{"key":"15_CR72","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1476-5381.2010.00791.x","volume":"160","author":"JM Jamontt","year":"2010","unstructured":"Jamontt JM, Molleman A, Pertwee RG et al (2010) The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. Br J of Pharmacol 160:712\u2013723","journal-title":"Br J of Pharmacol"},{"key":"15_CR73","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00262-004-0509-9","volume":"53","author":"J Joseph","year":"2004","unstructured":"Joseph J, Niggemann B, Zaenker KS et al (2004) Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol Immunother 53:723\u2013728","journal-title":"Cancer Immunol Immunother"},{"key":"15_CR74","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3892\/ol.2012.1081","volume":"5","author":"CK Jung","year":"2013","unstructured":"Jung CK, Kang WK, Park JM et al (2013) Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer. Oncol Lett 5:870\u2013876","journal-title":"Oncol Lett"},{"key":"15_CR75","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/j.1532-2149.2012.00147.x","volume":"16","author":"D Keszthelyi","year":"2012","unstructured":"Keszthelyi D, Troost FJ, Simren M et al (2012) Revisiting concepts of visceral nociception in irritable bowel syndrome. Eur J Pain 16:1444\u20131454","journal-title":"Eur J Pain"},{"key":"15_CR76","first-page":"G364","volume":"291","author":"ES Kimball","year":"2006","unstructured":"Kimball ES, Schneider CR, Wallace NH et al (2006) Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. Am J Physiol 291:G364\u2013G371","journal-title":"Am J Physiol"},{"key":"15_CR77","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1124\/jpet.110.175778","volume":"338","author":"SG Kinsey","year":"2011","unstructured":"Kinsey SG, Nomura DK, O\u2019Neal ST et al (2011) Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice. J Pharmacol Exp Ther 338:795\u2013802","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR78","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1365-2982.2010.01587.x","volume":"23","author":"TK Klooker","year":"2011","unstructured":"Klooker TK, Leliefeld KE, Van Den Wijngaard RM et al (2011) The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients. Neurogastroenterol Motil 23:30\u201335","journal-title":"Neurogastroenterol Motil"},{"key":"15_CR79","doi-asserted-by":"publisher","first-page":"G140","DOI":"10.1152\/ajpgi.00317.2013","volume":"307","author":"LC Koay","year":"2014","unstructured":"Koay LC, Rigby RJ, Wright KL (2014) Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 307:G140\u2013G148","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/MEG.0b013e328349bb4c","volume":"23","author":"S Lal","year":"2011","unstructured":"Lal S, Prasad N, Ryan M et al (2011) Cannabis use amongst patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 23:891\u2013896","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"15_CR81","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1053\/gast.2002.36025","volume":"123","author":"A Lehmann","year":"2002","unstructured":"Lehmann A, Blackshaw LA, Br\u00e4nd\u00e9n L (2002) Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs. Gastroenterology 123:1129\u20131134","journal-title":"Gastroenterology"},{"key":"15_CR82","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuropharm.2013.03.029","volume":"71","author":"K Li","year":"2013","unstructured":"Li K, Fichna J, Schicho R et al (2013) A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. Neuropharmacology 71:255\u2013263","journal-title":"Neuropharmacology"},{"key":"15_CR83","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0016-5085(03)00881-3","volume":"125","author":"A Ligresti","year":"2003","unstructured":"Ligresti A, Bisogno T, Matias I et al (2003) Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125:677\u2013687","journal-title":"Gastroenterology"},{"key":"15_CR84","first-page":"2583","volume":"30","author":"M Linsalata","year":"2010","unstructured":"Linsalata M, Notarnicola M, Tutino V et al (2010) Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. Anticancer Res 30:2583\u20132589","journal-title":"Anticancer Res"},{"key":"15_CR85","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1194\/jlr.M012153","volume":"52","author":"JZ Long","year":"2011","unstructured":"Long JZ, LaCava M, Jin X et al (2011) An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase. J Lipid Res 52:337\u2013344","journal-title":"J Lipid Res"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","volume":"168","author":"K Mackie","year":"2005","unstructured":"Mackie K (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol 168:299\u2013325","journal-title":"Handb Exp Pharmacol"},{"key":"15_CR87","doi-asserted-by":"publisher","first-page":"G863","DOI":"10.1152\/ajpgi.00482.2003","volume":"286","author":"WK MacNaughton","year":"2004","unstructured":"MacNaughton WK, Van Sickle MD, Keenan CM et al (2004) Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves. Am J Physiol Gastrointest Liver Physiol 286:G863\u2013G871","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"15_CR88","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/sj.bjp.0703229","volume":"129","author":"RS Martin","year":"2000","unstructured":"Martin RS, Luong LA, Welsh NJ et al (2000) Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human. Br J Pharmacol 129:1707\u20131715","journal-title":"Br J Pharmacol"},{"key":"15_CR89","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1464-410X.2010.09583.x","volume":"108","author":"FV Merriam","year":"2011","unstructured":"Merriam FV, Wang ZY, Hillard CJ et al (2011) Inhibition of fatty acid amide hydrolase suppresses referred hyperalgesia induced by bladder inflammation. BJU Int 108:1145\u20131149","journal-title":"BJU Int"},{"key":"15_CR90","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.drudis.2010.03.007","volume":"15","author":"GG Muccioli","year":"2010","unstructured":"Muccioli GG (2010) Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today 15:474\u2013483","journal-title":"Drug Discov Today"},{"issue":"6","key":"15_CR91","doi-asserted-by":"publisher","first-page":"1514.e1515","DOI":"10.1016\/j.urology.2009.12.051","volume":"75","author":"G Mukerji","year":"2010","unstructured":"Mukerji G, Yiangou Y, Agarwal SK et al (2010) Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms. Urology 75(6):1514.e1515\u20131514.e1520","journal-title":"Urology"},{"key":"15_CR92","first-page":"455","volume":"13","author":"T Naftali","year":"2011","unstructured":"Naftali T, Lev LB, Yablecovitch D, Half E et al (2011) Treatment of Crohn\u2019s disease with cannabis: an observational study. Isr Med Assoc J 13:455\u2013458","journal-title":"Isr Med Assoc J"},{"key":"15_CR93","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1159\/000358155","volume":"32","author":"T Naftali","year":"2014","unstructured":"Naftali T, Mechulam R, Lev LB et al (2014) Cannabis for inflammatory bowel disease. Dig Dis 32:468\u2013474","journal-title":"Dig Dis"},{"key":"15_CR94","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1124\/jpet.108.143487","volume":"329","author":"PS Naidu","year":"2009","unstructured":"Naidu PS, Booker L, Cravatt BF et al (2009) Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception. J Pharmacol Exp Ther 329:48\u201356","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"15_CR95","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S0367-326X(00)00171-4","volume":"71","author":"E Nocerino","year":"2000","unstructured":"Nocerino E, Amato M, Izzo AA (2000) Cannabis and cannabinoid receptors. Fitoterapia 71(Suppl 1):S6\u2013S12","journal-title":"Fitoterapia"},{"key":"15_CR96","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/bph.12360","volume":"170","author":"LD O\u2019Brien","year":"2013","unstructured":"O\u2019Brien LD, Limebeer CL, Rock EM et al (2013) Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus). Br J Pharmacol 170:1130\u20131136","journal-title":"Br J Pharmacol"},{"key":"15_CR97","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","volume":"3","author":"HA Overton","year":"2006","unstructured":"Overton HA, Babbs AJ, Doel SM et al (2006) Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3:167\u2013175","journal-title":"Cell Metab"},{"key":"15_CR156","first-page":"1009","volume":"10","author":"E Pagano","year":"2015","unstructured":"Pagano E, Montanaro V, Di Girolamo A et al (2015) Effect of non-psychotropic plant-derived cannabinoids on bladder contractility: focus on cannabigerol. Nat Prod Commun 10:1009\u20131012","journal-title":"Nat Prod Commun"},{"key":"15_CR98","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/j.1476-5381.2010.01176.x","volume":"163","author":"LA Parker","year":"2011","unstructured":"Parker LA, Rock EM, Limebeer CL (2011) Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol 163:1411\u20131422","journal-title":"Br J Pharmacol"},{"key":"15_CR99","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00213-014-3696-x","volume":"232","author":"LA Parker","year":"2014","unstructured":"Parker LA, Niphakis MJ, Downey R et al (2014) Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus. Psychopharmacology 232:583\u201393","journal-title":"Psychopharmacology"},{"key":"15_CR100","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1113\/jphysiol.2003.042242","volume":"550","author":"ER Partosoedarso","year":"2003","unstructured":"Partosoedarso ER, Abrahams TP, Scullion RT et al (2003) Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets. J Physiol 550:149\u2013158","journal-title":"J Physiol"},{"key":"15_CR101","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1136\/gut.2005.073403","volume":"54","author":"HA Patsos","year":"2005","unstructured":"Patsos HA, Hicks DJ, Dobson RR et al (2005) The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut 54:1741\u20131750","journal-title":"Gut"},{"key":"15_CR102","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1369\/jhc.2008.950741","volume":"56","author":"MR Pazos","year":"2008","unstructured":"Pazos MR, Tol\u00f3n RM, Benito C et al (2008) Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa. J Histochem Cytochem 56:511\u2013516","journal-title":"J Histochem Cytochem"},{"key":"15_CR103","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1111\/j.1476-5381.1996.tb15643.x","volume":"118","author":"RG Pertwee","year":"1996","unstructured":"Pertwee RG, Fernando SR (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118:2053\u20132058","journal-title":"Br J Pharmacol"},{"issue":"4","key":"15_CR104","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.juro.2014.11.083","volume":"193","author":"F Pessina","year":"2015","unstructured":"Pessina F, Capasso R, Borrelli F et al (2015) Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis. J Urol 193(4):1401\u20131408","journal-title":"J Urol"},{"key":"15_CR105","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1097\/01.MIB.0000435851.94391.37","volume":"19","author":"J Ravikoff Allegretti","year":"2013","unstructured":"Ravikoff Allegretti J, Courtwright A, Lucci M et al (2013) Marijuana use patterns among patients with inflammatory bowel disease. Inflamm Bowel Dis 19:2809\u20132814","journal-title":"Inflamm Bowel Dis"},{"key":"15_CR106","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","volume":"350","author":"M Rinaldi-Carmona","year":"1994","unstructured":"Rinaldi-Carmona M, Barth F, Heaulme M et al (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240\u2013244","journal-title":"FEBS Lett"},{"key":"15_CR107","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/bph.12322","volume":"170","author":"EM Rock","year":"2013","unstructured":"Rock EM, Sticht MA, Duncan M et al (2013) Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and \u0394(9)\u2014tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. Br J Pharmacol 170:671\u2013678","journal-title":"Br J Pharmacol"},{"key":"15_CR108","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00221-014-3942-9","volume":"232","author":"EM Rock","year":"2014","unstructured":"Rock EM, Limebeer CL, Parker LA (2014) Anticipatory nausea in animal models: a review of potential novel therapeutic treatments. Exp Brain Res 232:2511\u20132534","journal-title":"Exp Brain Res"},{"key":"15_CR109","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/bph.12120","volume":"169","author":"B Romano","year":"2013","unstructured":"Romano B, Borrelli F, Fasolino I et al (2013) The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. Br J Pharmacol 169:213\u2013229","journal-title":"Br J Pharmacol"},{"key":"15_CR110","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.phymed.2013.11.006","volume":"21","author":"B Romano","year":"2014","unstructured":"Romano B, Borrelli F, Pagano E et al (2014) Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. Phytomedicine 21:631\u2013639","journal-title":"Phytomedicine"},{"key":"15_CR111","first-page":"595","volume":"64","author":"M Rutkowska","year":"2009","unstructured":"Rutkowska M, Fereniec-Go\u0142ebiewska L (2009) Involvement of nitric oxide in the gastroprotective effect of ACEA, a selective cannabinoid CB1 receptor agonist, on aspirin-induced gastric ulceration. Pharmazie 64:595\u2013597","journal-title":"Pharmazie"},{"key":"15_CR112","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejphar.2007.05.016","volume":"570","author":"C Saitoh","year":"2007","unstructured":"Saitoh C, Kitada C, Uchida W et al (2007) The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder. Eur J Pharmacol 570:182\u2013187","journal-title":"Eur J Pharmacol"},{"key":"15_CR113","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.crohns.2014.01.025","volume":"8","author":"M Salaga","year":"2014","unstructured":"Salaga M, Mokrowiecka A, Zakrzewski PK et al (2014) Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH). J Crohns Colitis 8:998\u20131009","journal-title":"J Crohns Colitis"},{"key":"15_CR114","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0306-4522(01)00584-X","volume":"110","author":"C Salio","year":"2002","unstructured":"Salio C, Fischer J, Franzoni MF et al (2002) Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. Neuroscience 110:755\u2013764","journal-title":"Neuroscience"},{"key":"15_CR115","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/j.1365-2982.2006.00819.x","volume":"18","author":"M Sanson","year":"2006","unstructured":"Sanson M, Bueno L, Fioramonti J (2006) Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats. Neurogastroenterol Motil 18:949\u2013956","journal-title":"Neurogastroenterol Motil"},{"key":"15_CR116","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/ijc.24483","volume":"125","author":"A Santoro","year":"2009","unstructured":"Santoro A, Pisanti S, Grimaldi C et al (2009) Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon. Int J Cancer 125:996\u20131003","journal-title":"Int J Cancer"},{"key":"15_CR117","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1365-2036.2011.04576.x","volume":"33","author":"E Scarpellini","year":"2011","unstructured":"Scarpellini E, Blondeau K, Boecxstaens V (2011) Effect of rimonabant on oesophageal motor function in man. Aliment Pharmcol Ther 33:730\u2013737","journal-title":"Aliment Pharmcol Ther"},{"key":"15_CR118","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1586\/ecp.09.62","volume":"3","author":"R Schicho","year":"2010","unstructured":"Schicho R, Storr M (2010) Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies. Expert Rev Clin Pharmacol 3:193\u2013207","journal-title":"Expert Rev Clin Pharmacol"},{"key":"15_CR119","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000336871","volume":"89","author":"R Schicho","year":"2012","unstructured":"Schicho R, Storr M (2012) Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice. Pharmacology 89:149\u2013155","journal-title":"Pharmacology"},{"key":"15_CR120","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1111\/j.1460-9568.2007.05521.x","volume":"25","author":"KA Sharkey","year":"2007","unstructured":"Sharkey KA, Cristino L, Oland LD et al (2007) Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur J Neurosci 25:2773\u20132782","journal-title":"Eur J Neurosci"},{"key":"15_CR121","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejphar.2013.09.068","volume":"722","author":"KA Sharkey","year":"2014","unstructured":"Sharkey KA, Darmani NA, Parker LA (2014) Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol 722:134\u2013146","journal-title":"Eur J Pharmacol"},{"key":"15_CR122","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5056\/jnm.2010.16.3.281","volume":"16","author":"L Shen","year":"2010","unstructured":"Shen L, Yang XJ, Qian W et al (2010) The role of peripheral cannabinoid receptors type 1 in rats with visceral hypersensitivity induced by chronic restraint stress. J Neurogastroenterol Motil 16:281\u2013290","journal-title":"J Neurogastroenterol Motil"},{"key":"15_CR123","first-page":"93","volume":"60","author":"N Shujaa","year":"2009","unstructured":"Shujaa N, Zadori ZS, Ronai AZ et al (2009) Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat. J Physiol Pharmacol 60:93\u2013100","journal-title":"J Physiol Pharmacol"},{"key":"15_CR124","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00109-006-0040-x","volume":"84","author":"A Sibaev","year":"2006","unstructured":"Sibaev A, Massa F, Y\u00fcce B et al (2006) CB1 and TRPV1 receptors mediate protective effects on colonic electrophysiological properties in mice. J Mol Med 84:513\u2013520","journal-title":"J Mol Med"},{"key":"15_CR125","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.taap.2011.11.005","volume":"258","author":"UP Singh","year":"2012","unstructured":"Singh UP, Singh NP, Singh B et al (2012) Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-\/-) mice by attenuating the activation of T cells and promoting their apoptosis. Toxicol Appl Pharmacol 258:256\u2013267","journal-title":"Toxicol Appl Pharmacol"},{"key":"15_CR126","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000136838","volume":"17","author":"RD Sofia","year":"1978","unstructured":"Sofia RD, Diamantis W, Edelson J (1978) Effect of delta9-tetrahydrocannabinol on the gastrointestinal tract of the rat. Pharmacology 17:79\u201382","journal-title":"Pharmacology"},{"key":"15_CR127","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.1158\/1078-0432.CCR-04-0653","volume":"10","author":"LT Soumaoro","year":"2004","unstructured":"Soumaoro LT, Uetake H, Higuchi T et al (2004) Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 10:8465\u20138471","journal-title":"Clin Cancer Res"},{"key":"15_CR128","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1111\/j.1476-5381.2011.01407.x","volume":"165","author":"MA Sticht","year":"2012","unstructured":"Sticht MA, Long JZ, Rock EM et al (2012) Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats. Br J Pharmacol 165:2425\u20132435","journal-title":"Br J Pharmacol"},{"key":"15_CR129","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00109-008-0359-6","volume":"86","author":"MA Storr","year":"2008","unstructured":"Storr MA, Keenan CM, Emmerdinger D (2008) Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. J Mol Med 86:925\u2013936","journal-title":"J Mol Med"},{"key":"15_CR130","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/ibd.20960","volume":"15","author":"MA Storr","year":"2009","unstructured":"Storr MA, Keenan CM, Zhang H et al (2009) Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm Bowel Dis 15:1678\u20131685","journal-title":"Inflamm Bowel Dis"},{"key":"15_CR131","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.eururo.2011.09.002","volume":"61","author":"F Strittmatter","year":"2012","unstructured":"Strittmatter F, Gandaglia G, Benigni F et al (2012) Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats. Eur Urol 61:98\u2013106","journal-title":"Eur Urol"},{"key":"15_CR132","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pain.2007.03.008","volume":"133","author":"M Suard\u00edaz","year":"2007","unstructured":"Suard\u00edaz M, Estivill-Torr\u00fas G, Goicoechea C et al (2007) Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain. Pain 133:99\u2013110","journal-title":"Pain"},{"key":"15_CR133","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1002\/cne.22382","volume":"518","author":"J Su\u00e1rez","year":"2010","unstructured":"Su\u00e1rez J, Romero-Zerbo SY, Rivera P et al (2010) Endocannabinoid system in the adult rat circumventricular areas: an immunohistochemical study. J Comp Neurol 518:3065\u20133085","journal-title":"J Comp Neurol"},{"key":"15_CR134","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1016\/j.bmc.2013.06.010","volume":"21","author":"A Tourteau","year":"2013","unstructured":"Tourteau A, Andrzejak V, Body-Malapel M et al (2013) 3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis. Bioorg Med Chem 21:5383\u20135394","journal-title":"Bioorg Med Chem"},{"key":"15_CR135","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.juro.2008.11.078","volume":"181","author":"V Tyagi","year":"2009","unstructured":"Tyagi V, Philips BJ, Su R et al (2009) Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol 181:1932\u20131938","journal-title":"J Urol"},{"key":"15_CR136","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0014-2999(00)00843-8","volume":"409","author":"K Tyler","year":"2000","unstructured":"Tyler K, Hillard CJ, Greenwood-Van Meerveld B (2000) Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats. Eur J Pharmacol 409:207\u2013211","journal-title":"Eur J Pharmacol"},{"key":"15_CR137","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1053\/gast.2001.28466","volume":"121","author":"MD Van Sickle","year":"2001","unstructured":"Van Sickle MD, Oland LD, Ho W et al (2001) Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology 121:767\u2013774","journal-title":"Gastroenterology"},{"key":"15_CR138","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.1115740","volume":"310","author":"MD Van Sickle","year":"2005","unstructured":"Van Sickle MD, Duncan M, Kingsley PJ et al (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310:329\u2013332","journal-title":"Science"},{"key":"15_CR139","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nrc3247","volume":"12","author":"G Velasco","year":"2012","unstructured":"Velasco G, S\u00e1nchez C, Guzm\u00e1n M (2012) Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 12:436\u2013444","journal-title":"Nat Rev Cancer"},{"key":"15_CR140","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00429-012-0425-2","volume":"218","author":"G Veress","year":"2013","unstructured":"Veress G, Meszar Z, Muszil D et al (2013) Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons. Brain Struct Funct 218:733\u2013750","journal-title":"Brain Struct Funct"},{"key":"15_CR141","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.1523\/JNEUROSCI.4507-11.2012","volume":"32","author":"CR Vianna","year":"2012","unstructured":"Vianna CR, Donato J Jr, Rossi J et al (2012) Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility. J Neurosci 32:10331\u201310337","journal-title":"J Neurosci"},{"key":"15_CR142","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1744-8069-7-31","volume":"7","author":"JS Walczak","year":"2011","unstructured":"Walczak JS, Cervero F (2011) Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents. Mol Pain 7:31","journal-title":"Mol Pain"},{"key":"15_CR143","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.neuroscience.2009.01.050","volume":"159","author":"JS Walczak","year":"2009","unstructured":"Walczak JS, Price TJ, Cervero F (2009) Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity. Neuroscience 159:1154\u20131163","journal-title":"Neuroscience"},{"key":"15_CR144","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1172\/JCI24086","volume":"115","author":"EC Wang","year":"2005","unstructured":"Wang EC, Lee JM, Ruiz WG et al (2005) ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest 115:2412\u20132422","journal-title":"J Clin Invest"},{"key":"15_CR145","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-08-0896","volume":"68","author":"D Wang","year":"2008","unstructured":"Wang D, Wang H, Ning W et al (2008) Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res 68:6468\u20136476","journal-title":"Cancer Res"},{"key":"15_CR146","doi-asserted-by":"publisher","first-page":"R846","DOI":"10.1152\/ajpregu.00585.2012","volume":"304","author":"ZY Wang","year":"2013","unstructured":"Wang ZY, Wang P, Bjorling DE (2013) Activation of cannabinoid receptor 2 inhibits experimental cystitis. Am J Physiol Regul Integr Comp Physiol 304:R846\u2013R853","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"15_CR147","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s10620-014-3212-5","volume":"59","author":"J Wang","year":"2014","unstructured":"Wang J, Zheng J, Kulkarni A et al (2014) Palmitoylethanolamide regulates development of intestinal radiation injury in a mast cell-dependent manner. Dig Dis Sci 59:2693\u20132703","journal-title":"Dig Dis Sci"},{"key":"15_CR148","first-page":"207","volume":"62","author":"Z Warzecha","year":"2011","unstructured":"Warzecha Z, Dembinski A, Ceranowicz P (2011) Role of sensory nerves in gastroprotective effect of anandamide in rats. J Physiol Pharmacol 62:207\u2013217","journal-title":"J Physiol Pharmacol"},{"key":"15_CR149","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.juro.2009.12.093","volume":"183","author":"P Weinhold","year":"2010","unstructured":"Weinhold P, Gratzke C, Streng T et al (2010) TRPA1 receptor induced relaxation of the human urethra involves TRPV1 and cannabinoid receptor mediated signals, and cyclooxygenase activation. J Urol 183:2070\u20132076","journal-title":"J Urol"},{"key":"15_CR150","doi-asserted-by":"publisher","first-page":"1638\u20131647.e1","DOI":"10.1053\/j.gastro.2011.07.036","volume":"141","author":"BS Wong","year":"2011","unstructured":"Wong BS, Camilleri M, Busciglio I et al (2011) Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. Gastroenterology 141:1638\u20131647.e1\u20131638\u20131647.e7","journal-title":"Gastroenterology"},{"key":"15_CR151","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","volume":"129","author":"K Wright","year":"2005","unstructured":"Wright K, Rooney N, Feeney M et al (2005) Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 129:437\u2013453","journal-title":"Gastroenterology"},{"key":"15_CR152","doi-asserted-by":"publisher","first-page":"509.e1","DOI":"10.1016\/j.urology.2010.03.029","volume":"76","author":"T Yamada","year":"2010","unstructured":"Yamada T, Ueda T, Shibata Y et al (2010) TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer. Urology 76:509.e1\u2013509.e7","journal-title":"Urology"},{"key":"15_CR153","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.canlet.2011.03.007","volume":"307","author":"L Ye","year":"2011","unstructured":"Ye L, Zhang B, Seviour EG et al (2011) Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer. Cancer Lett 307:6\u201317","journal-title":"Cancer Lett"},{"key":"15_CR154","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejphar.2014.01.047","volume":"727","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Wang XL, Mo FF et al (2014) Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. Eur J Pharmacol 727:99\u2013105","journal-title":"Eur J Pharmacol"}],"container-title":["Handbook of Experimental Pharmacology","Endocannabinoids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-20825-1_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T16:19:49Z","timestamp":1748621989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-20825-1_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319208244","9783319208251"],"references-count":156,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-20825-1_15","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-319-20825-1","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}